U.S. FDA plans to double drug inspectors in India as marketing applications soar

EJ Lane The U.S. FDA is hiring new inspectors in India to tackle the high rate of marketing applications made by local firms, an agency official said. FiercePharma News

Shooting for $5B in sales, India’s Lupin says it can actually hit U.S. launch goal this year

EJ Lane SINGAPORE–Despite missing its target for bringing 15 to 20 drugs to the U.S. market last year, Lupin is optimistic enough about 2015 that it seeks possible acquisitions ...

U.S. Chamber knocks IP laggards India, Indonesia, Thailand and Vietnam in Asia

EJ Lane SINGAPORE–India, Indonesia, Thailand and Vietnam are at the bottom in terms of protections for intellectual property, and much of the rest of Asia is ranked near them ...

U.S. judge blesses Pfizer’s $325M settlement in Neurontin class action

Carly Helfand A decade-long class action lawsuit against Pfizer over alleged off-label Neurontin marketing is finally wrapping up, with U.S. District Judge Patti Saris approving a $ ...

UCB joins pharma’s slimdown craze, unloads U.S. generic drug business for $1.53B

Emily Wasserman Amid the pharma's slimdown craze, Belgium's UCB is getting in on the action by selling its U.S. generic drug unit for $ 1.53 billion. FiercePharma News

Sanofi’s U.S. sales team gets its close-up–and a promised makeover

Tracy Staton Sanofi's U.S. diabetes sales team is under a worldwide spotlight–and not because it's time to take a bow. FiercePharma News

India’s Wockhardt profit freefalls as FDA bans devastate U.S. sales

Eric Palmer How bad can an FDA ban on plants be when the U.S. is your primary market? Really bad, India's Wockhardt found out this quarter, with its profit dropping more than $ ...

Little Cortendo gains $11M for late-stage Cushing’s study, hatches U.S. IPO plans

John Carroll Cortendo is coming to America. Founded in Sweden, the little biotech has a new CEO who's building the executive team in the Philadelphia area. And he's dropping ...

Jobs saved as Boehringer Ingelheim finds Chinese buyer for U.S. plant set to close

Eric Palmer About 240 workers at a Boehringer Ingelheim complex in Virginia will have something special to celebrate this Thanksgiving: the prospect of keeping their jobs. Just weeks ...

A tale of ‘two worlds’ for Novartis respiratory launches in U.S. and EU

Tracy Staton Targeting different markets naturally requires using different marketing strategies. But for Novartis, which is aiming to become a major respiratory player, its approaches ...

Will Pfizer rebid for AstraZeneca? Keep an eye on U.S. midterm election for clues

Tracy Staton Will Pfizer come back at AstraZeneca? That's been the question of the summer, especially since the U.S. Treasury Department rolled out new rules for tax-inversion deals. FiercePharma ...

Roche persuades U.S. judge to toss $2M Accutane verdict

Carly Helfand Roche has emerged victorious in its quest to reverse a $ 2.1 million verdict by a New Jersey jury in favor of a woman who blamed the Swiss pharma's acne med Accutane ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS